Hypertension, renin-angiotensin-aldosterone-system-blocking agents, and COVID-19

BACKGROUND: There have been concerns regarding the safety of renin-angiotensin-aldosterone-system (RAAS)-blocking agents including angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) during the coronavirus disease 2019 (COVID-19) pandemic. This study sought to eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Si-Hyuck, Lee, Dong-Hoon, Han, Kyung-Do, Jung, Jin-Hyung, Park, Sang-Hyun, Dai, Andrew M., Wei, Henry G., Yoon, Chang-Hwan, Youn, Tae-Jin, Chae, In-Ho, Kim, Cheol-Ho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166420/
https://www.ncbi.nlm.nih.gov/pubmed/34059140
http://dx.doi.org/10.1186/s40885-021-00168-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8166420/
https://www.ncbi.nlm.nih.gov/pubmed/34059140
http://dx.doi.org/10.1186/s40885-021-00168-0

Ejemplares similares